Founders Financial Alliance’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-536
| Closed | -$20.8K | – | 628 |
|
|
2024
Q4 | $20.8K | Sell |
536
-75
| -12% | -$2.91K | 0.01% | 439 |
|
|
2024
Q3 | $27.5K | Sell |
611
-6
| -1% | -$270 | 0.01% | 432 |
|
|
2024
Q2 | $25.8K | Sell |
617
-31
| -5% | -$1.29K | 0.01% | 422 |
|
|
2024
Q1 | $29.5K | Hold |
648
| – | – | 0.01% | 416 |
|
|
2023
Q4 | $30K | Hold |
648
| – | – | 0.01% | 375 |
|
|
2023
Q3 | $26.4K | Hold |
648
| – | – | 0.01% | 365 |
|
|
2023
Q2 | $31.4K | Sell |
648
-43
| -6% | -$2.09K | 0.01% | 380 |
|
|
2023
Q1 | $34.5K | Sell |
691
-1
| -0.1% | -$50 | 0.02% | 331 |
|
|
2022
Q4 | $35K | Hold |
692
| – | – | 0.02% | 354 |
|
|
2022
Q3 | $35K | Buy |
+692
| New | +$35K | 0.02% | 346 |
|
|
2022
Q2 | – | Sell |
-842
| Closed | -$51K | – | 520 |
|
|
2022
Q1 | $51K | Sell |
842
-94
| -10% | -$5.69K | 0.02% | 321 |
|
|
2021
Q4 | $74K | Hold |
936
| – | – | 0.03% | 323 |
|
|
2021
Q3 | $83K | Hold |
936
| – | – | 0.04% | 291 |
|
|
2021
Q2 | $93K | Hold |
936
| – | – | 0.04% | 301 |
|
|
2021
Q1 | $84K | Buy |
936
+395
| +73% | +$35.4K | 0.04% | 286 |
|
|
2020
Q4 | $51K | Buy |
541
+75
| +16% | +$7.07K | 0.03% | 293 |
|
|
2020
Q3 | $34K | Buy |
+466
| New | +$34K | 0.02% | 455 |
|